Viracta Therapeutics (VIRX) Q4 2023 Earnings

7MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.35
-0.33
-0.3
-0.28

Details

Expected EPS
-0.31
Actual EPS
-0.35
Surprise EPS
-0.04
Surprise Percent
+12.9%

Description

Viracta Therapeutics (VIRX) has reported earnings of -0.35 per share for Q4 2023.

0 Comments

Share your thoughts